-
Je něco špatně v tomto záznamu ?
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision
JL. Brożek, J. Bousquet, I. Agache, A. Agarwal, C. Bachert, S. Bosnic-Anticevich, R. Brignardello-Petersen, GW. Canonica, T. Casale, NH. Chavannes, J. Correia de Sousa, AA. Cruz, CA. Cuello-Garcia, P. Demoly, M. Dykewicz, I....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, směrnice pro lékařskou praxi
- MeSH
- alergická rýma farmakoterapie epidemiologie MeSH
- antagonisté histaminu H1 terapeutické užití MeSH
- antialergika terapeutické užití MeSH
- bronchiální astma prevence a kontrola MeSH
- dítě MeSH
- klinické rozhodování MeSH
- kvalita života MeSH
- lékařská praxe založená na důkazech MeSH
- lidé MeSH
- zvířata MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- směrnice pro lékařskou praxi MeSH
BACKGROUND: Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of life and school and work performance and is a frequent reason for office visits in general practice. Medical costs are large, but avoidable costs associated with lost work productivity are even larger than those incurred by asthma. New evidence has accumulated since the last revision of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines in 2010, prompting its update. OBJECTIVE: We sought to provide a targeted update of the ARIA guidelines. METHODS: The ARIA guideline panel identified new clinical questions and selected questions requiring an update. We performed systematic reviews of health effects and the evidence about patients' values and preferences and resource requirements (up to June 2016). We followed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence-to-decision frameworks to develop recommendations. RESULTS: The 2016 revision of the ARIA guidelines provides both updated and new recommendations about the pharmacologic treatment of AR. Specifically, it addresses the relative merits of using oral H1-antihistamines, intranasal H1-antihistamines, intranasal corticosteroids, and leukotriene receptor antagonists either alone or in combination. The ARIA guideline panel provides specific recommendations for the choice of treatment and the rationale for the choice and discusses specific considerations that clinicians and patients might want to review to choose the management most appropriate for an individual patient. CONCLUSIONS: Appropriate treatment of AR might improve patients' quality of life and school and work productivity. ARIA recommendations support patients, their caregivers, and health care providers in choosing the optimal treatment.
Alfred Hospital and Monash University Melbourne Australia
Allergy and Respiratory Diseases IRCCS San Martino IST University of Genoa Genoa Italy
Allergy Department 2nd Pediatric Clinic University of Athens Athens Greece
Asthma and Allergy Clinic Humanitas University Rozzano Milan Italy
Center of Rhinology and Allergology Wiesbaden Germany
Department of Allergy and Rheumatology Ajou University School of Medicine Suwon Korea
Department of Clinical Epidemiology and Biostatistics McMaster University Hamilton Ontario Canada
Department of Dermatology and Allergy Charité Universitätsmedizin Berlin Berlin Germany
Department of Family Medicine McMaster University Hamilton Ontario Canada
Department of Medicine Royal College of Surgeons in Ireland Medical School Dublin Ireland
Department of Otorhinolaryngology Academic Medical Centre Amsterdam The Netherlands
Department of Paediatrics Oslo University Hospital University of Oslo Oslo Norway
Department of Pediatrics Division of Allergy and Immunology University of California San Diego Calif
Department of Pediatrics Nippon Medical School Tokyo Japan
Department of Pediatrics University of Antioquia Medellin Colombia
Department of Public Health and Primary Care Leiden University Medical Center Leiden The Netherlands
Division of Allergy and Immunology University of South Florida Tampa Fla
Faculty of Medicine Transylvania University Brasov Romania
Hospital Médica Sur Mexico City Mexico
Institute of Family Medicine and Public Health University of Tartu Tartu Estonia
National Hospital Organization Tokyo National Hospital Kiyose city Tokyo Japan
Nova Southeastern University Fort Lauderdale Fla
ProAR Center of Excellence for Asthma Federal University of Bahia Salvador Brazil
School of Medicine University of Antioquia Medellín Colombia
School of Medicine University of Toronto Toronto Ontario Canada
University Clinic of Pulmonary and Allergic Diseases Golnik Golnik Slovenia
University Hospital Montpellier France
University of Aberdeen Aberdeen United Kingdom
Upper Airways Research Laboratory Ghent University Hospital Ghent Belgium
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016555
- 003
- CZ-PrNML
- 005
- 20180516111228.0
- 007
- ta
- 008
- 180515s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jaci.2017.03.050 $2 doi
- 035 __
- $a (PubMed)28602936
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Brożek, Jan L $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. Electronic address: jan.l.brozek@gmail.com.
- 245 10
- $a Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision / $c JL. Brożek, J. Bousquet, I. Agache, A. Agarwal, C. Bachert, S. Bosnic-Anticevich, R. Brignardello-Petersen, GW. Canonica, T. Casale, NH. Chavannes, J. Correia de Sousa, AA. Cruz, CA. Cuello-Garcia, P. Demoly, M. Dykewicz, I. Etxeandia-Ikobaltzeta, ID. Florez, W. Fokkens, J. Fonseca, PW. Hellings, L. Klimek, S. Kowalski, P. Kuna, KT. Laisaar, DE. Larenas-Linnemann, KC. Lødrup Carlsen, PJ. Manning, E. Meltzer, J. Mullol, A. Muraro, R. O'Hehir, K. Ohta, P. Panzner, N. Papadopoulos, HS. Park, G. Passalacqua, R. Pawankar, D. Price, JJ. Riva, Y. Roldán, D. Ryan, B. Sadeghirad, B. Samolinski, P. Schmid-Grendelmeier, A. Sheikh, A. Togias, A. Valero, A. Valiulis, E. Valovirta, M. Ventresca, D. Wallace, S. Waserman, M. Wickman, W. Wiercioch, JJ. Yepes-Nuñez, L. Zhang, Y. Zhang, M. Zidarn, T. Zuberbier, HJ. Schünemann,
- 520 9_
- $a BACKGROUND: Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of life and school and work performance and is a frequent reason for office visits in general practice. Medical costs are large, but avoidable costs associated with lost work productivity are even larger than those incurred by asthma. New evidence has accumulated since the last revision of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines in 2010, prompting its update. OBJECTIVE: We sought to provide a targeted update of the ARIA guidelines. METHODS: The ARIA guideline panel identified new clinical questions and selected questions requiring an update. We performed systematic reviews of health effects and the evidence about patients' values and preferences and resource requirements (up to June 2016). We followed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence-to-decision frameworks to develop recommendations. RESULTS: The 2016 revision of the ARIA guidelines provides both updated and new recommendations about the pharmacologic treatment of AR. Specifically, it addresses the relative merits of using oral H1-antihistamines, intranasal H1-antihistamines, intranasal corticosteroids, and leukotriene receptor antagonists either alone or in combination. The ARIA guideline panel provides specific recommendations for the choice of treatment and the rationale for the choice and discusses specific considerations that clinicians and patients might want to review to choose the management most appropriate for an individual patient. CONCLUSIONS: Appropriate treatment of AR might improve patients' quality of life and school and work productivity. ARIA recommendations support patients, their caregivers, and health care providers in choosing the optimal treatment.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antialergika $x terapeutické užití $7 D018926
- 650 _2
- $a bronchiální astma $x prevence a kontrola $7 D001249
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a klinické rozhodování $7 D000066491
- 650 _2
- $a lékařská praxe založená na důkazech $7 D055317
- 650 _2
- $a antagonisté histaminu H1 $x terapeutické užití $7 D006634
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a kvalita života $7 D011788
- 650 _2
- $a alergická rýma $x farmakoterapie $x epidemiologie $7 D065631
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 700 1_
- $a Bousquet, Jean $u University Hospital, Montpellier, France.
- 700 1_
- $a Agache, Ioana $u Faculty of Medicine, Transylvania University, Brasov, Romania.
- 700 1_
- $a Agarwal, Arnav $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; School of Medicine, University of Toronto, Toronto, Ontario, Canada.
- 700 1_
- $a Bachert, Claus $u Upper Airways Research Laboratory, Ghent University Hospital, Ghent, Belgium.
- 700 1_
- $a Bosnic-Anticevich, Sinthia $u Woolcock Institute, University of Sydney, Sydney, Australia.
- 700 1_
- $a Brignardello-Petersen, Romina $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
- 700 1_
- $a Canonica, G Walter $u Asthma & Allergy Clinic, Humanitas University, Rozzano, Milan, Italy.
- 700 1_
- $a Casale, Thomas $u Division of Allergy and Immunology, University of South Florida, Tampa, Fla.
- 700 1_
- $a Chavannes, Niels H $u Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
- 700 1_
- $a Correia de Sousa, Jaime $u Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, and ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
- 700 1_
- $a Cruz, Alvaro A $u ProAR-Center of Excellence for Asthma, Federal University of Bahia, Salvador, Brazil.
- 700 1_
- $a Cuello-Garcia, Carlos A $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
- 700 1_
- $a Demoly, Pascal $u University Hospital of Montpellier, Montpellier, and Sorbonne Universités, UPMC Paris 06, UMR-S 1136, IPLESP, Equipe EPAR, Paris, France.
- 700 1_
- $a Dykewicz, Mark $u Section of Allergy and Immunology, Department of Internal Medicine, Saint Louis University School of Medicine, St Louis, Mo.
- 700 1_
- $a Etxeandia-Ikobaltzeta, Itziar $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Dirección de Investigación e Innovación Sanitaria, Departamento de Salud, Gobierno Vasco-Eusko Jaurlaritza, Vitoria-Gasteiz, Spain.
- 700 1_
- $a Florez, Ivan D $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Department of Pediatrics, University of Antioquia, Medellin, Colombia.
- 700 1_
- $a Fokkens, Wytske $u Department of Otorhinolaryngology, Academic Medical Centre, Amsterdam, The Netherlands.
- 700 1_
- $a Fonseca, Joao $u CINTESIS-Center for Health Technology and Services Research, Faculdade de Medicina, Universidade do Porto & Allergy, CUF Porto Hospital and Instituto, Porto, Portugal.
- 700 1_
- $a Hellings, Peter W $u Department of Otorhinolaryngology, University Hospitals Leuven, and the Department of Otorhinolaryngology, Academic Medical Center (AMC), Amsterdam, The Netherlands.
- 700 1_
- $a Klimek, Ludger $u Center of Rhinology and Allergology, Wiesbaden, Germany.
- 700 1_
- $a Kowalski, Sergio $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
- 700 1_
- $a Kuna, Piotr $u Division of Internal Medicine Asthma and Allergy, Faculty of Medicine, Medical University of Lodz, Lodz, Poland.
- 700 1_
- $a Laisaar, Kaja-Triin $u Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.
- 700 1_
- $a Larenas-Linnemann, Désirée E $u Hospital Médica Sur, Mexico City, Mexico.
- 700 1_
- $a Lødrup Carlsen, Karin C $u Department of Paediatrics, Oslo University Hospital, University of Oslo, Oslo, Norway.
- 700 1_
- $a Manning, Peter J $u Department of Medicine, Royal College of Surgeons in Ireland Medical School, Dublin, Ireland.
- 700 1_
- $a Meltzer, Eli $u Department of Pediatrics, Division of Allergy & Immunology, University of California, San Diego, Calif.
- 700 1_
- $a Mullol, Joaquim $u Unitat de Rinologia i Clínica de l'Olfacte, Servei d'ORL, Hospital Clínic, Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, Barcelona, Spain.
- 700 1_
- $a Muraro, Antonella $u Department of Women and Child Health & Food Allergy Referral Centre Veneto Region, University of Padua, Padua, Italy.
- 700 1_
- $a O'Hehir, Robyn $u Alfred Hospital and Monash University, Melbourne, Australia.
- 700 1_
- $a Ohta, Ken $u National Hospital Organization Tokyo National Hospital, Kiyose-city, Tokyo, Japan.
- 700 1_
- $a Panzner, Petr $u Department of Immunology and Allergology, Faculty of Medicine in Pilsen, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Papadopoulos, Nikolaos $u Allergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece; Division of Infection, Immunity & Respiratory Medicine, University of Manchester, Manchester, United Kingdom.
- 700 1_
- $a Park, Hae-Sim $u Department of Allergy and Rheumatology, Ajou University School of Medicine, Suwon, Korea.
- 700 1_
- $a Passalacqua, Gianni $u Allergy and Respiratory Diseases, IRCCS San Martino, IST, University of Genoa, Genoa, Italy.
- 700 1_
- $a Pawankar, Ruby $u Department of Pediatrics, Nippon Medical School, Tokyo, Japan.
- 700 1_
- $a Price, David $u University of Aberdeen, Aberdeen, United Kingdom.
- 700 1_
- $a Riva, John J $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Department of Family Medicine, McMaster University, Hamilton, Ontario, Canada.
- 700 1_
- $a Roldán, Yetiani $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
- 700 1_
- $a Ryan, Dermot $u Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom.
- 700 1_
- $a Sadeghirad, Behnam $u HIV/STI Surveillance Research Center, and World Health Organization Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.
- 700 1_
- $a Samolinski, Boleslaw $u Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
- 700 1_
- $a Schmid-Grendelmeier, Peter $u Allergy Unit, Department of Dermatology, University Hospital of Zürich and Christine Kühne Center for Allergy Research and Education CK-CARE, Davos, Switzerland.
- 700 1_
- $a Sheikh, Aziz $u Asthma UK Centre for Applied Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom.
- 700 1_
- $a Togias, Alkis $u Asthma and Inflammation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
- 700 1_
- $a Valero, Antonio $u Department of Pneumology and Allergy, Immunoallèrgia Respiratòria Clínica I Experimental (IDIBAPS), Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
- 700 1_
- $a Valiulis, Arunas $u Vilnius University Clinic of Children's Diseases and Public Health Institute, Vilnius, and the European Academy of Paediatrics (EAP/UEMS-SP), Brussels, Belgium.
- 700 1_
- $a Valovirta, Erkka $u Department of Lung Diseases and Clinical Immunology, University of Turku and Allergy Clinic Terveystalo Turku, Turku, Finland.
- 700 1_
- $a Ventresca, Matthew $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
- 700 1_
- $a Wallace, Dana $u Nova Southeastern University, Fort Lauderdale, Fla.
- 700 1_
- $a Waserman, Susan $u Division of Clinical Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- 700 1_
- $a Wickman, Magnus $u Department of Pediatrics, Sachs' Children's Hospital, South General Hospital and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
- 700 1_
- $a Wiercioch, Wojtek $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
- 700 1_
- $a Yepes-Nuñez, Juan José $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; School of Medicine, University of Antioquia, Medellín, Colombia.
- 700 1_
- $a Zhang, Luo $u Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital and Beijing Institute of Otolaryngology, Beijing, China.
- 700 1_
- $a Zhang, Yuan $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
- 700 1_
- $a Zidarn, Mihaela $u University Clinic of Pulmonary and Allergic Diseases Golnik, Golnik, Slovenia.
- 700 1_
- $a Zuberbier, Torsten $u Department of Dermatology and Allergy, Charité-Universitätsmedizin Berlin, Berlin, Germany.
- 700 1_
- $a Schünemann, Holger J $u Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Division of General Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
- 773 0_
- $w MED00002505 $t The Journal of allergy and clinical immunology $x 1097-6825 $g Roč. 140, č. 4 (2017), s. 950-958
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28602936 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180516111403 $b ABA008
- 999 __
- $a ok $b bmc $g 1300179 $s 1013395
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 140 $c 4 $d 950-958 $e 20170608 $i 1097-6825 $m Journal of allergy and clinical immunology $n J Allergy Clin Immunol $x MED00002505
- LZP __
- $a Pubmed-20180515
